Evidence map›Paper›PMID 42078198›Full record

ReviewMedical review (2021)2026

How to efficiently establish animal models of cholangiocarcinoma: challenges and inspiration.

Ruiqiang Gou, Ping Yue, Peng Liu, Jinyu Zhao, Chunfei Huang, Kiyohito Tanaka, Peng F Wong, Rungsun Rerknimitr, Jong H Moon, Tan T Cheung and 8 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Medical review (2021), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Ruiqiang GouThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.ORCID https://orcid.org/0000-0002-9257-4786
Ping YueGeneral Surgery Department of the First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Peng LiuSchool of Pharmacy, Lanzhou University, Lanzhou, Gansu, China.
Jinyu ZhaoThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Chunfei HuangThe First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
Kiyohito TanakaDepartment of Gastroenterology, Kyoto Second Red Cross Hospital, Kyoto, Japan.
Peng F WongDepartment of Vascular Surgery, James Cook University Hospital, Midlands, UK.
Rungsun RerknimitrThe Center for Innovation and Endoscopy in Gastrointestinal Oncology of Chulalongkorn University, Bangkok, Thailand.
Jong H MoonDeparment of Internal Medicine, SoonChunHyang University Bucheon Hospital, Bucheon, Korea.
Tan T CheungDepartment of Surgery, The University of Hong Kong, Hong Kong, China.
Christian WaydhasDepartment of Trauma Surgery, Essen University Hospital, Essen D-45121, Germany.ORCID https://orcid.org/0000-0002-5291-0853
Azumi SuzukiDepartment of Gastroenterology, Hamamatsu Medical Center, Hamamatsu, Japan.
Yanyan LinGeneral Surgery Department of the First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Emmanuel MelloulDepartment of Visceral Surgery, University Hospital of Lausanne, Lausanne, Switzerland, Switzerland.
Hans SchlittRegensburg University Hospital Center Surgery Department, Regensburg 93053, Germany.
John FungInstitute of Transplantation, Department of Surgery, University of Chicago, Chicago, USA.
Joseph W LeungDepartment of Gastroenterology and Hepatology, University of California, Davis Medical Center and Sacramento Veterans Affairs Medical Center, Sacramento, USA.
Wenbo MengGeneral Surgery Department of the First Hospital of Lanzhou University, Lanzhou, Gansu, China.ORCID https://orcid.org/0000-0002-9355-0225

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cholangiocarcinoma (CCA) consists of a class of malignant tumors of the biliary system, with a rising incidence and carries a poor prognosis. Developing reliable animal models of CCA is crucial to elucidate the pathogenesis, identify novel therapeutic targets, and assess treatment efficacy. Among these models, the

Indexed as

animal modelcholangiocarcinomamodelingtherapeutic potential

Identifiers

PMID42078198
PMCPMC13134702

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.